Literature DB >> 11359741

The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis.

J R Ortlepp1, R Hoffmann, F Ohme, J Lauscher, F Bleckmann, P Hanrath.   

Abstract

OBJECTIVE: To test the hypothesis that vitamin D receptor polymorphism is associated with calcific aortic valve stenosis.
DESIGN: The distribution of one polymorphism of the vitamin D receptor (BsmI B/b) was examined in 100 consecutive patients with calcific valvar aortic stenosis and compared with a control group of 100 patients (paired match for age, sex, and the presence of coronary artery disease from a total of 630 patients without calcified aortic valves). Polymerase chain reaction and restriction fragment length polymorphism were used to determine genotypes.
RESULTS: There was a significant difference in vitamin D receptor allele and genotype frequencies between the two groups. The allele B had a higher prevalence in patients with calcific aortic stenosis (B = 0.56, b = 0.44) than in the control cohort (B = 0.40, b = 0.60) (p = 0.001).
CONCLUSIONS: There is a significant association of vitamin D receptor polymorphism with calcific aortic valve stenosis. The B allele of the vitamin D receptor is more common in patients with calcific aortic valve stenosis. It now needs to be evaluated whether other genes that control calcium homeostasis are involved in the pathogenesis of this disorder.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359741      PMCID: PMC1729782          DOI: 10.1136/heart.85.6.635

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  23 in total

Review 1.  Valvular heart disease.

Authors:  B A Carabello; F A Crawford
Journal:  N Engl J Med       Date:  1997-07-03       Impact factor: 91.245

2.  Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.

Authors:  B F Stewart; D Siscovick; B K Lind; J M Gardin; J S Gottdiener; V E Smith; D W Kitzman; C M Otto
Journal:  J Am Coll Cardiol       Date:  1997-03-01       Impact factor: 24.094

3.  Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: the OFELY Study.

Authors:  P Garnero; O Borel; E Sornay-Rendu; M E Arlot; P D Delmas
Journal:  J Bone Miner Res       Date:  1996-06       Impact factor: 6.741

4.  Vitamin D receptor polymorphism, bone mineral density, and osteoporotic vertebral fracture: studies in a UK population.

Authors:  L A Houston; S F Grant; D M Reid; S H Ralston
Journal:  Bone       Date:  1996-03       Impact factor: 4.398

5.  Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin.

Authors:  N A Morrison; R Yeoman; P J Kelly; J A Eisman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

6.  Prediction of bone density from vitamin D receptor alleles.

Authors:  N A Morrison; J C Qi; A Tokita; P J Kelly; L Crofts; T V Nguyen; P N Sambrook; J A Eisman
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

7.  Temporal changes in the causes of aortic stenosis: a surgical pathologic study of 646 cases.

Authors:  C S Passik; D M Ackermann; J R Pluth; W D Edwards
Journal:  Mayo Clin Proc       Date:  1987-02       Impact factor: 7.616

8.  Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density.

Authors:  S Ferrari; R Rizzoli; T Chevalley; D Slosman; J A Eisman; J P Bonjour
Journal:  Lancet       Date:  1995-02-18       Impact factor: 79.321

9.  Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype.

Authors:  B Dawson-Hughes; S S Harris; S Finneran
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

10.  Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies.

Authors:  C M Otto; J Kuusisto; D D Reichenbach; A M Gown; K D O'Brien
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

View more
  31 in total

1.  Cardiovascular risk factors in patients with aortic stenosis predict prevalence of coronary artery disease but not of aortic stenosis: an angiographic pair matched case-control study.

Authors:  J R Ortlepp; F Schmitz; T Bozoglu; P Hanrath; R Hoffmann
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

2.  Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.

Authors:  Ashvin R Kamath; Ramdas G Pai
Journal:  Int J Angiol       Date:  2008

3.  Relationship of PON1 192 and 55 gene polymorphisms to calcific valvular aortic stenosis.

Authors:  Luis M Moura; Susana Faria; Miguel Brito; Fausto J Pinto; Steen D Kristensen; Isabel M Barros; Nalini Rajamannan; Francisco Rocha-Gonçalves
Journal:  Am J Cardiovasc Dis       Date:  2012-05-15

Review 4.  Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

Authors:  Nalini M Rajamannan; Frank J Evans; Elena Aikawa; K Jane Grande-Allen; Linda L Demer; Donald D Heistad; Craig A Simmons; Kristyn S Masters; Patrick Mathieu; Kevin D O'Brien; Frederick J Schoen; Dwight A Towler; Ajit P Yoganathan; Catherine M Otto
Journal:  Circulation       Date:  2011-10-18       Impact factor: 29.690

Review 5.  Biomarkers of Calcific Aortic Valve Disease.

Authors:  Aeron Small; Daniel Kiss; Jay Giri; Saif Anwaruddin; Hasan Siddiqi; Marie Guerraty; Julio A Chirinos; Giovanni Ferrari; Daniel J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-02-02       Impact factor: 8.311

6.  Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study.

Authors:  Jason P Linefsky; Kevin D O'Brien; Ronit Katz; Ian H de Boer; Eddy Barasch; Nancy S Jenny; David S Siscovick; Bryan Kestenbaum
Journal:  J Am Coll Cardiol       Date:  2011-07-12       Impact factor: 24.094

Review 7.  Aortic valve sclerosis as a marker of active atherosclerosis.

Authors:  Kelley R Branch; Kevin D O'Brien; Catherine M Otto
Journal:  Curr Cardiol Rep       Date:  2002-03       Impact factor: 2.931

8.  Assessment of risk factors for developing incident aortic stenosis: the Tromsø Study.

Authors:  Gry Wisthus Eveborn; Henrik Schirmer; Per Lunde; Geir Heggelund; John-Bjarne Hansen; Knut Rasmussen
Journal:  Eur J Epidemiol       Date:  2014-07-15       Impact factor: 8.082

9.  Relationship of bone mineral density with valvular and annular calcification in community-dwelling older people: The Cardiovascular Health Study.

Authors:  Daniele Massera; Shuo Xu; Traci M Bartz; Anna E Bortnick; Joachim H Ix; Michel Chonchol; David S Owens; Eddy Barasch; Julius M Gardin; John S Gottdiener; John R Robbins; David S Siscovick; Jorge R Kizer
Journal:  Arch Osteoporos       Date:  2017-05-30       Impact factor: 2.617

10.  Reduced EGFR causes abnormal valvular differentiation leading to calcific aortic stenosis and left ventricular hypertrophy in C57BL/6J but not 129S1/SvImJ mice.

Authors:  Cordelia J Barrick; Reade B Roberts; Mauricio Rojas; Nalini M Rajamannan; Carolyn B Suitt; Kevin D O'Brien; Susan S Smyth; David W Threadgill
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-15       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.